1-6 of 6
Jean Oak, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy

Brian Sworder, MD PhD, David M. Kurtz, MD PhD, Charles Macaulay, MSc, BA, Matthew J. Frank, MD PhD, Stefan Alig, MD, Andrea Garofalo, BS, BA, Bita Sahaf, PhD, Mohammad Shahrokh Esfahani, Jay Y. Spiegel, MDFRCPC, Jean Oak, MD PhD, Sara Beygi, MD, Michael C. Jin, BS, Jacob J Chabon, Michael S. Khodadoust, MD PhD, Robbie G. Majzner, MD, Crystal L. Mackall, MD, Maximilian Diehn, MD PhD, David B Miklos, MD PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 550.
https://doi.org/10.1182/blood-2019-129015
Published: 2019
Journal Articles

Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction

Liora M Schultz, MD, Shabnum Patel, PhD, Sneha Ramakrishna, MD, Alice Bertaina, MD PhD, Neehar Bhatia, Jean Oak, MD PhD, Robbie G. Majzner, MD, Christina Baggott, RN, PhD, Kara L. Davis, DO, Crystal L. Mackall, MD, Steven A Feldman, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4471.
https://doi.org/10.1182/blood-2019-129436
Published: 2019
Journal Articles

Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies

Nasheed Hossain, MD, Bita Sahaf, PhD, Matthew Abramian, PhD, Jay Y. Spiegel, MD, Katie Kong, Stephen Kim, Sharon Mavroukakis, Jean Oak, MD PhD, Yasodha Natkunam, MD PhD, Everett H Meyer, MD PhD, Matthew J. Frank, MD PhD, Steven A Feldman, PhD, Steven R. Long, MD, Haiying Qin, MS, Terry J. Fry, MD, Lori S Muffly, MD, Crystal L. Mackall, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 490.
https://doi.org/10.1182/blood-2018-99-110142
Published: 2018
Journal Articles

Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma

Jay Y. Spiegel, MD, Bita Sahaf, PhD, Nasheed Hossain, MD, Matthew J. Frank, MD PhD, Gursharan Claire, MPH, Matthew Abramian, PhD, Theresa Latchford, RN, Bertha Villa, MPH, Juancarlos Cancilla, Jean Oak, MD PhD, Yasodha Natkunam, MD PhD, Steven R. Long, MD, Sally Arai, MD, Laura J Johnston, MD, Robert Lowsky, MD, Everett H Meyer, MD PhD, Lori S Muffly, MD, Robert S. Negrin, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Katherine A. Kong, Crystal L. Mackall, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 576.
https://doi.org/10.1182/blood-2018-99-113261
Published: 2018
Journal Articles

Target Antigen Downregulation and Other Mechanisms of Failure after Axicabtagene Ciloleucel (CAR19) Therapy

Jean Oak, MD PhD, Jay Y. Spiegel, MD, Bita Sahaf, PhD, Yasodha Natkunam, MD PhD, Steven R. Long, MD, Nasheed Hossain, MD, Crystal L. Mackall, MD, Katherine A. Kong, David B. Miklos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4656.
https://doi.org/10.1182/blood-2018-99-120206
Published: 2018
Journal Articles

Transfusion Dependence Is Common in Adults with Hemophagocytic Lymphohistiocytosis (HLH) and Is Associated with EBV Viremia

Yazan Migdady, MDMSc, Haley Weiner, Eric Lau, DO, Beth A Martin, MD, Michael R. Jeng, MD, Jean Oak, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3737.
https://doi.org/10.1182/blood.V130.Suppl_1.3737.3737
Published: 2017